Published in:
01-12-2021 | Rheumatoid Arthritis | Original Article
IgA rheumatoid factor is associated with bone mineral density preservation in rheumatoid arthritis
Published in: Clinical Rheumatology | Issue 12/2021
Login to get accessAbstract
Introduction
Autoantibodies such as IgM rheumatoid factor (RF) and anti-citrullinated proteins/peptides antibodies (ACPA) have previously been incriminated in systemic bone loss in rheumatoid arthritis (RA). There are, however, no data describing association of IgA RF and IgG RF with systemic bone loss.
Objective
This study was aimed to investigate the association of RF isotypes with systemic bone loss among patients with RA.
Methods
RF isotypes and ACPA were measured by enzyme-linked immunosorbent assay among 153 patients with RA. Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry.
Results
Ninety-four (61.4%) patients had positive IgA RF, 89 (58.2%) had positive IgG RF, 109 (71.2%) had positive IgM RF, whereas 122 (80.3%) RA patients tested positive for ACPA. Compared to the IgA RF-negative patients, IgA RF-positive patients exhibited higher disease activity and had higher RF titers.
Seven (4.6%) patients had low BMD at femoral neck, 12 (7.8%) at total femur, and 47 (30.7%) at lumbar spine. IgA RF was found to be associated with protection against low BMD at spine (OR = 0.47, 95% CI = 0.23–0.95, p = 0.034). This association was further confirmed in the multivariate regression analysis taking into account several potential confounding factors (OR = 0.21, 95% CI = 0.06–0.65, p = 0.039). No association between low BMD and the presence of IgG RF or IgM RF or ACPA was found.
Conclusion
IgA RF for the first time ever was shown to be associated with BMD preservation at spine in RA.
Key points • IgA RF was associated with protection against low spinal BMD. • No association between low BMD and the presence of IgG RF or IgM RF was found. |